Envoi LLC’s Eli Lilly LLY Stock Holding History

Envoi LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-306	Closed	-$238K	–	24
2024 Q1	$238K	Buy	+306	New	+$218K	0.56%	27

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Envoi LLC's LLY Position: Q2 2024 in Review

Envoi LLC sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 306 shares — an estimated $238K sold.

Envoi LLC first reported a position in LLY in Q1 2024 and held it in 1 quarter. The position peaked at $238K in Q1 2024. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

Envoi LLC reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
Envoi LLC sold 306 Eli Lilly shares in Q2 2024, an estimated $238K.
Envoi LLC first reported a position in Eli Lilly in Q1 2024 and held it in 1 quarter.
Envoi LLC's Eli Lilly position peaked at $238K in Q1 2024.
3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Envoi LLC's 13F filing for Q2 2024, filed 13 Aug 2024.